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with an immunohistochemical analysis
Kimihide Kusafuka*, Tomoko Miki and Takashi NakajimaAbstract
Background: The early phase of salivary gland carcinomas with high-grade transformation (HGT) is extremely rare.
We reported one case of adenoid cystic carcinoma (AdCC) with early HGT, herein.
Case presentation: The patient was a 27-year-old Japanese woman who suffered from swelling of the left parotid
region. Most of this tumor consisted of typical AdCC histology, whereas the central area of this tumor was composed
of solid growth component by atypical cells with clear cytoplasm and marked nuclear atypia. Immunohistochemically,
this area was strongly and diffusely positive for epithelial membrane antigen, p53, p16, Her-2, cyclin A and cyclin B1.
The Ki-67 labeling index of this area was high, entirely different from that of AdCC area.
Conclusion: Overall, this area was an early phase of AdCC-HGT. This case is the second case of early AdCC-HGT. We
discuss the development of salivary gland carcinoma with HGT.
Virtual Slides: http://www.diagnosticpatology.diagnomx.eu/vx/1598278104895730
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The concept of dedifferentiation or high-grade trans-
formation (HGT) in salivary gland carcinoma derived
from the one of bone and soft tissue sarcomas. Cheuk
et al. reported the adenoid cystic carcinomas (AdCC)
with HGT in 1999 [1]. Ide et al. reported the incipient
phase of AdCC-HGT [2], but the early phase of the
HGT of AdCC remains unclear. We report herein one
additional case showing the early phase of HGT in sali-
vary AdCC.Case presentation
Clinical history
The patient was a 27-year-old Japanese woman who
suffered from the swelling of the left parotid region.
She had never admitted to any other hospitals
for 9 years, and then, she admitted to our hospital.
Computed tomography indicated a 30 × 20 × 25 mm
irregular-shaped mass was seen in the left parotid gland.* Correspondence: k.kusafuka@scchr.jp
Pathology Division, Shizuoka Cancer Center, 1007 Shimonagakubo,
Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
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reproduction in any medium, provided the orMagnetic resonance imaging showed an irregular-shaped
mass, which showed the low intensity with T1-weight
imaging and the low and partly high intensity with
T2-weight imaging (Figure 1). Total parotidectomy and
neck dissection were performed one month later under
the clinical diagnosis of parotid gland carcinoma.
Multiple lung metastases, pelvic metastasis and loco-
regional recurrence were observed two months after opera-
tion. Although the palliative radiotherapy was performed,
she died of disease 6 months after the operation. Autopsy
was not permitted.Pathological findings
Macroscopically, an ill-defined grayish-white mass was
observed in the left parotid gland (Figure 2). Histologi-
cally, most part of the tumor showed a cribriform
growth pattern of the relatively small tumor cells,
which could be diagnosed as typical AdCC (Figure 3A,
B,C), whereas about 10% of the tumor was composed of
the solid subtype of AdCC (grade II) (Figure 3D). In the
central portion of the tumor (approximately 10% of this
tumor: the size was 7 × 5 mm), an entirely differental Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance imaging (T2 weight imaging)
showed an irregularly lobulated mass with irregularly
low-intensity and partly high-intensity (white arrows) in the left
parotid gland.
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of solid and sheet-like growth by atypical cells with clear
cytoplasm and marked nuclear atypia (Figure 3E). The
tumor cells in this area, which were larger than typical
AdCC cells, showed prominent nucleoli and irregular-
shaped nuclei (Figure 3F). Such a component lackedFigure 2 Macroscopically, the tumor showed an ill-defined
mass, and a nodular focus (arrows) in the main lesion (white
dotted lines are the sectioning lines). The nodular focus was
comparable to the HGT component.ductal-myoepithelial differentiation. Although necrosis
was seen, perineural invasion, and angiolymphatic inva-
sion were not observed in “the sheet-like area”. There
was no transitional zone between conventional AdCC
areas and “the sheet-like area”. In AdCC component,
periodic acid-Schiff (PAS)-positive lumens were seen,
but “the sheet-like area” was negative for PAS and
Alcian blue staining. The surgical margin was positive
and the extraglandular extension was observed. Immu-
nohistochemistry was performed on the deparaffinized
tissue sections using the primary antibodies listed in
Table 1 and the EnVision (DakoCytomation, Carpinteria,
CA, USA) method. Immunostaining showed that the
only true lumen of the typical AdCC portion was posi-
tive for epithelial membrane antigen (EMA), whereas
“the sheet-like area” was diffusely positive for EMA.
The AdCC area was positive for S-100 protein, p63, and
cytokeratin (CK) 14 and alpha-smooth muscle actin,
whereas “the sheet-like area” was negative for such anti-
gens, except for the positivity for p63 and CK14 in the
myoepithelial cells (Figure 4). Moreover, the AdCC area
was weakly positive for Her-2 and the negativity for
p16, whereas “the sheet-like area” revealed diffuse and
strong positivity for such antigens. The AdCC area
showed sporadic positivity for p53, cyclin A and cyclin
B1, whereas “the sheet-like area” revealed diffuse and
strong positivity for such antigens. The Ki-67 labeling
index of the AdCC area and “the sheet-like area”
showed 34.5% and 73.2%, respectively (Figure 5A). “The
sheet-like area” indicated the overexpression of p53,
p16, Her-2, cyclin A and cyclin B1 (Figure 5B,C,D,E),
different from those of the typical AdCC.
Finally, we diagnosed this case as “AdCC with an early
phase of HGT”.
Discussion
The tumor in this case consisted of three different com-
ponents: lower-grade (cribriform subtype) of AdCC,
solid-subtype AdCC and HGT. As three components
existed separately, we believe that HGT occurs abruptly in
typical AdCC. In the present case, HGT component
lacked biphasic differentiation. Recently, Costa et al.
reported three major criteria of AdCC-HGT [3]; 1)
proliferation of tumor cells at least a focal loss of
myoepithelial cells surrounding tumor nests, 2) nu-
clear size at least 2–3 times the size of tubular/cribri-
form AdCC nuclei and 3) thickened irregular nuclear
membranes and prominent nucleoli in a majority of
cells. The present case fulfilled at least the above 3
criteria. On the other hand, as HGT component was
composed of atypical clear cells, the differential diag-
nosis with clear cell carcinoma, not otherwise specified
(CCCNOS) or myoepithelial carcinoma is needed. How-
ever, CCCNOS is usually a low-grade malignant tumor
Figure 3 Histological findings of the present case. A high-grade carcinoma (black dotted line), which was different from the adenoid cystic
carcinoma (AdCC) component (blue line), was seen in the central area of this tumor (A: whole mount H&E stain section). A focus of high-grade
carcinoma (asterisk) was well demarcated in typical AdCC area and no gradual transition zone was seen (black dotted line) (B: H&E stain x20).
Typical of AdCC showed a cribriform pattern (C: H&E stain x200). Solid subtype of AdCC was seen partly (arrow shows cribriform pattern within
the solid subtype of AdCC.) (D: H&E stain x200). High-grade carcinoma showed solid and insular growth (E: H&E stain x200) with clear cytoplasm
and marked nuclear atypia (F: H&E stain x400).
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diffusely positive for p63 [4]. Therefore, “the sheet-like
area” is not CCCNOS component. Clear cell type of
myoepithelial carcinoma showed the positivity for
myoepithelial markers, such as ASMA and p63 [5].
Therefore, “the sheet-like area” is not the component of
myoepitehlial carcinoma. Moreover, the present case is
different from low-grade cribriform cystadenocarcinoma
(LGCCC), carcinoma ex pleomorphic adenoma (CXPA)and other rare tumors such as an epithelioid
angiosarcoma. Usually, LGCCC shows the intraductal
lesions with surrounding by p63-positive myo-
epithelial cells without atypia [6]. The present case
showed cribriform pattern, but the tumor was not
intraductal lesion. The criteria of CXPA are the malig-
nant tumor, which usually consist of salivary duct carcin-
oma component, arising from benign pleomorphic
adenoma [7]. The present case never contained the
Table 1 The antibodies used in this study and their results
Antibody ACC HGT
Antigens Clone Source Cribriform Solid
EMA E29 DakoCytomation (Carpinteria, CA, USA) + + ++
GCDFP-15 NCL-GCDFP15 Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK) - - -
Her-2 DakoCytomation (Carpinteria CA) - 1+ 3+
EGFR NCL-L-EGFR Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK) - - -
AR AR441 DakoCytomation (Carpinteria, CA, USA) - - -
CK5/6 D5/16 B4 DakoCytomation (Carpinteria, CA, USA) + + -(myo+)
S-100 DakoCytomation (Carpinteria, CA, USA) + + -
ASMA 1A4 DakoCytomation (Carpinteria, CA, USA) ++ + -
calponin CALP DakoCytomation (Carpinteria, CA, USA) + f+ -
CK14 LL002 Chemicon International (Temecula, CA, USA) + p+ -(myo+)
p63 4A4 Lab Vision (Fremont, CA, USA) ++ p+ -(myo+)
mammaglobin 304-1A5 DakoCytomation (Carpinteria, CA, USA) - f+
p53 DO-7 DakoCytomation (Carpinteria, CA, USA) f+ p+ ++
cyclin A NCL-CYCLN A Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK) 10.3% 17.3% 34.5%
cyclin B1 NCL-CYCLN B1 Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK) 0.5% 12.2% 50.3%
cyclin D1 DSC-6 DakoCytomation (Carpinteria CA, USA) - 1.1% -
cylcin E NCL-CYCLN E Novocastra Laboratories Ltd. (New Castle Upon Tyne, UK) - - -
p16 G175-405 BD Biosciences (Franklin Lakes, NJ, USA) f+ p+ ++
MDM2 SMP14 Themo Fisher Scientific (Cheshire, UK) - - -
Ki-67L.I. MIB-1 DakoCytomation (Carpinteria, CA, USA) 34.5% 49.7% 73.2%
ACC, adenoid cystic carcinoma area; HGT, high-grade transformation area.
EMA, epithelial membrane antigen; GCDFP-15, gross cystic disease fluid protein-15; EGFR. Epidermal growth factor receptor; AR, androgen receptor; CK,
cytokeratin; ASMA, alpha-smooth muscle actin.
—, negative; f+, focally positive (1-9%); p+, partially positive (10-19%); +, positive (20-60%); ++, diffusely positive (>60%); myo, myoepithelial cells.
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giosarcoma rarely occurs in the salivary gland, and
tumor cells are infrequently positive for CK and p63
[8]. However, epithelioid angiosarcoma focally shows
sinusoid-like spaces and is also positive for vimentin
and CD31. The present case was negative for vimentin
and CD31 (date not shown), and showed no findings
such as sinusoid-like spaces.
HGT is recognized when a lower-grade malignant
neoplasm abruptly transforms to a high-grade [9,10],
in which the high-grade component is juxtaposed to
the original lesion or the original line of differenti-
ation is lost [1]. This concept should be distinguished
from malignancy from arising a benign tumor such
as CXPA, hybrid tumors, and transformation within a
high-grade carcinoma to another high-grade pattern
[11]. However, the gradually successive transition from
solid-subtype AdCC to HGT was also reported [12].
Recently, Seethala et al. indicated that, in the HGT
area of AdCC, the Ki-67 labeling index was >50%,
and commonly showed the diffuse and strong im-
munopositivity of p53 protein [13]. Although Chauet al. indicated that, in AdCC-HGT, p53 gene muta-
tion and overexpression of cyclin D1 and Her-2 were
related to the dedifferentiation process [14], the ac-
cumulation of p53 gene product and overexpression
of cyclin A, cyclin B1, and Her-2 were related to
such a phenomenon in the present case. Overall,
“the sheet-like area” of this tumor was high-grade
carcinoma, which was considered the early phase of
AdCC-HGT. The HGT component might have gene
mutation of p53 and p16, and moreover, amplifica-
tion of the Her-2 gene, which suggested that this
component had the higher-grade malignancy. Nagao
et al. reported 6 cases of HGT-AdCC and suggested
that the HGT process was related to p53 gene muta-
tion, overexpression of Her-2 and loss of pRb gene
products [10]. In HGT of AdCC, the overexpression of
p16 may be related to loss of pRb gene products, not
human papilloma virus infection [15]. In the genetic
analyses on AdCC with HGT, the increase of c-Myc
gene and a low level increase of Her-2 gene in HGT
areas were observed, but the role of Her-2 in AdCC-
HGT still remains unclear [16]. However, the present
Figure 4 The immuno-phenotypes of high-grade carcinoma, comparing with those of typical AdCC. The high-grade carcinoma
component showed strong and diffuse positivity for EMA (A: immunostaining x200), whereas the typical AdCC component showed limited
positivity forthe true lumens in the cribriform growth area (B: immunostaining x200). The high-grade carcinoma component was negative for
ASMA (C: immunostainng x200: the blood vessels were positive), whereas the peripheral cells adjacent the pseudocysts in the AdCC area were
positive for ASMA (D: immunostaining x200). The high-grade carcinoma component was negative for p63 (E: immnostaining x200: the involved
myoepithelial cells were positive), whereas the peripheral cells adjacent the pseudocysts in typical AdCC area were positive for p63
(F: immunostaining x200).
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to HGT at least.
Among the salivary gland carcinomas, AdCC fre-
quently showed the HGT. Ide et al. reported that
early phase of AdCC-HGT consisted of the scattered
foci of anaplastic carcinoma in the co-/pre-existing
low-grade AdCC [2]. In series of AdCC-HGT reported
by Seethala et al., one case had only a 20% HGT com-
ponent in typical AdCC and another case contained
only a 10% HGT component, who died of disease [13].
As median percentage of HGT component is 70%,
which is reported by Seethela et al. [13], we considerthat if HGT component is less than 10%, it should be
included into the early phase of AdCC-HGT. The
present case contained no evidence of scattered high-
grade lesions, but one small focus of high-grade carcin-
oma existed in the central area of the AdCC. Ide et al.
do not descript on the proportion of HGT components
in the main tumor [2]. Sato et al. reported the gradual
progression from low-/intermediate-grade AdCC to
high-grade AdCC and moreover to AdCC-HGT [11].
The dedifferentiation or the HGT of the salivary gland
carcinomas might occur abruptly within the co-/
pre-existing low-grade carcinoma, as seen from the
Figure 5 Results of the immunohistochemical examination of high-grade carcinoma component in the present case. Typical
AdCC area showed low labeling index for Ki-67, whereas the high-grade carcinoma component (asterisk) showed a high Ki-67 labeling index
(A: immunostaining x20). The high-grade carcinoma component also showed strong and diffuse positivity for p53 (B: immunostaining x200: inset;
weakly positive for p53 in typical AdCC), Her-2 (C; inset; weakly positive for Her-2 in typical AdCC: immunostaining x400), p16 (D: immunostaining
x200: inset; focally positivity for p16 in typical AdCC; immunostaining x400), and cyclin A (E; immunostaining x200: inset; focally positivity for
cyclin A in typical AdCC; immunostaining x400), respectively.
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present case. In the present case, typical AdCC and
HGT components were also clearly demarcated, and no
findings of gradual progression were observed.
Conclusions
In summary the early phase of the AdCC-HGT was
derived from abruptly genetic and phenotypic changes.
The present case is the first report that an early phaseof AdCC-HGT was related to cyclin A, cyclin B1 and
p16 overexpression, in addition to p53 gene product
accumulation and Her-2 overexpression.Consent
Written informed consent was obtained from the pa-
tient for publication of this Case Report and any accom-
panying images.
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